Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

63 filings reported holding EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 50.2M shares of 105M outstanding shares and own 47.69% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (13.9M shares), Novo Holdings A/S (5.59M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.93M shares), Cormorant Asset Management, LP (3.57M shares), VIKING GLOBAL INVESTORS LP (2.73M shares), RA CAPITAL MANAGEMENT, L.P. (2.61M shares), FMR LLC (2.5M shares), CITADEL ADVISORS LLC (2.46M shares), BlackRock Inc. (2.05M shares), and New Leaf Venture Partners, L.L.C. (1.55M shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.